Janux Therapeutics, Inc.
financial.report · SEC EDGAR
This page reproduces a recorded source event. It is not a live quote, forecast, recommendation or legal conclusion.
Event type
financial.report
Occurred
2025-06-30
Reported
2025-08-07
Disclosure lag
38 days
Context
links are based on the recorded entity type| Field | Recorded value |
|---|---|
| Entity | Janux Therapeutics, Inc. |
| Source | SEC EDGAR ↗ |
| Source identifier | companyfacts/CIK0001817713/2026-07-26 |
| Event ID | #29433 |
Recorded payload
JSON payload as stored after parsing{
"accession": "0000950170-25-105069",
"canonical_covered": 11,
"canonical_total": 12,
"fiscal_period": "Q2",
"fiscal_year": 2025,
"form": "10-Q",
"mapped_tag_share": 0.05963302752293578,
"metrics": {
"cash_and_equivalents": 52446000,
"earnings_per_share_basic": -0.55,
"earnings_per_share_diluted": -0.55,
"net_income": -33858000,
"operating_income": -45118000,
"revenue": 0,
"shareholders_equity": 990516000,
"shares_outstanding": 59297814,
"total_assets": 1032212000,
"total_liabilities": 41696000
},
"metrics_reported": 10,
"period_end": "2025-06-30"
}Source: SEC EDGAR · as of 2025-08-07T00:00:00Z